Current Radiopharmaceuticals

Editor-in-Chief

Andrea Ciarmiello
Chief of Nuclear Medicine Unit and Imaging Department
S. Andrea Hospital
La Spezia
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 5 Issue: 4, October 2012



Editorial: [Hot Topic: The Role of Nuclear Medicine in the Management of Patients with Glioblastoma Multiforme] free to download

Volume:5   Issue: 4
Pp: 289-291
Ioannis N. Mavridis
DOI: 10.2174/1874471011205040289
Published on: 19 September, 2012

The Emerging Role of Stereotactic Radiosurgery in the Treatment of Glioblastoma Multiforme

Volume:5   Issue: 4
Pp: 292-299
Manlio Barbarisi and Pantaleo Romanelli
DOI: 10.2174/1874471011205040292
Published on: 19 September, 2012

Advanced Neuroimaging Techniques in the Management of Glioblastoma Multiforme

Volume:5   Issue: 4
Pp: 300-307
Claudio Colonnese and Pantaleo Romanelli
DOI: 10.2174/1874471011205040300
Published on: 19 September, 2012

Glioblastoma Multiforme Imaging: The Role of Nuclear Medicine

Volume:5   Issue: 4
Pp: 308-313
George A. Alexiou, Spyridon Tsiouris, Spyridon Voulgaris, Athanasios P. Kyritsis and Andreas D. Fotopoulos
DOI: 10.2174/1874471011205040308
Published on: 19 September, 2012

Synthesis of a Potent Cathepsin S Inhibitor Labeled with Deuterium and Carbon-14

Volume:5   Issue: 4
Pp: 314-317
Bachir Latli, Matt Hrapchak, Jon C. Lorenz, Carl A. Busacca and Chris Senanayake
DOI: 10.2174/1874471011205040314
Published on: 19 September, 2012

A Potencial Theranostic Agent for EGF-R Expression Tumors: 177Lu- DOTA-Nimotuzumab

Volume:5   Issue: 4
Pp: 318-324
Victoria Calzada, Xiuli Zhang, Marcelo Fernandez, Arlhee Diaz-Miqueli, Normando Iznaga-Escobar, Susan L. Deutscher, Henia Balter, Thomas P. Quinn and Pablo Cabral
DOI: 10.2174/1874471011205040318
Published on: 19 September, 2012

Future of Low Specific Activity Molybdenum-99/Technetium-99m Generator

Volume:5   Issue: 4
Pp: 325-328
A. Mushtaq
DOI: 10.2174/1874471011205040325
Published on: 19 September, 2012

Copper-62 Labeled ReCCMSH Peptide Analogs for Melanoma PET Imaging

Volume:5   Issue: 4
Pp: 329-335
Xiuli Zhang, Zhiwei Yue, Bao-Yuan Lu, Gerson J. Vazquez-Flores, Johnny Yuen, Said Daibes Figueroa, Fabio Gallazzi, Cathy Cutler, Thomas P. Quinn and Jeffrey L. Lacy
DOI: 10.2174/1874471011205040329
Published on: 19 September, 2012

Polymeric Nanoparticles of FMISO: Are Nano-Radiopharmaceuticals Better Than Conventional Ones?

Volume:5   Issue: 4
Pp: 336-339
Marta de Souza Albernaz, Beatriz Ferreira de Carvalho Patricio, Gilberto Weissmuller, Franceline Reynaud, Tom CH Adamsen and Ralph Santos-Oliveira
DOI: 10.2174/1874471011205040336
Published on: 19 September, 2012

109Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a Potential Agent for Targeted Tumor Therapy

Volume:5   Issue: 4
Pp: 340-347
Tapas Das, Sudipta Chakraborty, H. D. Sarma and Sharmila Banerjee
DOI: 10.2174/1874471011205040340
Published on: 19 September, 2012

Synthesis of [DTPA-bis(D-ser)] Chelate (DBDSC): An Approach for the Design of SPECT Radiopharmaceuticals Based on Technetium

Volume:5   Issue: 4
Pp: 348-355
Raunak Varshney, Swarndeep K. Sethi, Puja P. Hazari, Krishna Chuttani, Sachin Soni, Marilyn D. Milton and Anil K. Mishra
DOI: 10.2174/1874471011205040348
Published on: 19 September, 2012

Biodistribution and Pharmacokinetics of I-131 Labelled 4- Iodophenylacetic Acid

Volume:5   Issue: 4
Pp: 356-362
Jan Rijn Zeevaart, Zoltan Szucs, Tamsyn Pulker, Thato Sello, Jacqueline Bracher and Mike Sathekge
DOI: 10.2174/1874471011205040356
Published on: 19 September, 2012

Acknowledgement to reviewers

Volume:5   Issue: 4
Pp: 363-363

DOI: 10.2174/1874471011205040363
Published on: 19 September, 2012